Skip to main content
. 2022 Sep 15;28(9):1902–1912. doi: 10.1038/s41591-022-01913-0

Fig. 2. Community-wide FMT outcomes vary across patients and indications.

Fig. 2

a, Microbiome-level outcomes of 228 scorable allogenic FMT time series, summarized across all strain populations observed in donor and recipient (rec.). Fractions are normalized to the number of species observed in the recipient post FMT. b, Contextual data on indication, procedure and clinical outcome for each FMT time series in a.